Comparing Two Simple Nail Support Methods for Early Ingrown Toenails: Cotton Nail Cast vs. Gutter Splint

Efficacy of Cotton Nail Cast Versus Enhanced Gutter Splint in Early Stage Great Toe Onychocryptosis (Stage 1 and 2a):A Randomised Control Trial at a Tertiary care Centre in Mandya. - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094969

Enrollment

Registered

2025-09-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L600- Ingrowing nail

Interventions

Intervention1: Cotton nail cast: inserting a cotton U-cast beneath the ingrown nail margin and fixing it with cyanoacrylate adhesive to elevate the nail edge Intervention2: Cotton nail cast: Name: Co

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptomatic ingrown toenail (Stage I or IIa ) aged more than 18 years of age , both sexes attending the outpatient department of dermatology and willing to give written informed consent for the study.

Exclusion criteria

Exclusion criteria: Peripheral vascular disease. Active local infection or cellulitis. Immunocompromised status (e.g., HIV, Transplant recipients , Uncontrolled diabetes mellitus). Allergy to cyanoacrylate glue. Local deformity of the digit (e.g, Hallux varus/valgus).

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Cotton Nail Cast and Enhanced Gutter Splint Technique in Stage 1 & 2a Disease onychocryptosis patients attending the outpatient department of dermatology, MIMS , Mandya.Timepoint: Baseline (Day 0) Before intervention . Day 3, Day 7, 1 Month, 3 Months, and 6 Months. Symptom evaluation: pain, difficulty walking, shoe-wear limitation Clinical signs: erythema, swelling, granulation tissue, discharge Photographs: taken at baseline, and at 1, 3, and 6 months Pain scores: using Visual Analog Scale (VAS) Assessment of complications: recurrence, nail dystrophy, infection, abscess, scarring, or spike formation	—

Measure

Time frame

To compare the efficacy of Cotton Nail Cast and Enhanced Gutter Splint Technique in Stage 1 & 2a Disease onychocryptosis patients attending the outpatient department of dermatology, MIMS , Mandya.Timepoint: Baseline (Day 0) Before intervention . Day 3, Day 7, 1 Month, 3 Months, and 6 Months. Symptom evaluation: pain, difficulty walking, shoe-wear limitation Clinical signs: erythema, swelling, granulation tissue, discharge Photographs: taken at baseline, and at 1, 3, and 6 months Pain scores: using Visual Analog Scale (VAS) Assessment of complications: recurrence, nail dystrophy, infection, abscess, scarring, or spike formation

—

Secondary

Measure	Time frame
To evaluate and compare patient satisfaction, postoperative pain, healing time, and complications between the two treatment modalities. Timepoint: Baseline (Day 0) Before intervention . Day 3, Day 7, 1 Month, 3 Months, and 6 Months. Symptom evaluation: pain, difficulty walking, shoe-wear limitation Clinical signs: erythema, swelling, granulation tissue, discharge Photographs: taken at baseline, and at 1, 3, and 6 months Pain scores: using Visual Analog Scale (VAS) Assessment of complications: recurrence, nail dystrophy, infection, abscess, scarring, or spike formation	—

Measure

Time frame

To evaluate and compare patient satisfaction, postoperative pain, healing time, and complications between the two treatment modalities. Timepoint: Baseline (Day 0) Before intervention . Day 3, Day 7, 1 Month, 3 Months, and 6 Months. Symptom evaluation: pain, difficulty walking, shoe-wear limitation Clinical signs: erythema, swelling, granulation tissue, discharge Photographs: taken at baseline, and at 1, 3, and 6 months Pain scores: using Visual Analog Scale (VAS) Assessment of complications: recurrence, nail dystrophy, infection, abscess, scarring, or spike formation

—

Countries

India

Contacts

Public ContactDr Shashikumar B M

Mandya institute of medical sciences, Mandya

shashikumarbm@gmail.com9886197902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026